Effect of glatiramer acetate (Copaxone) given orally in human patients: interleukin-10 production during a phase 1 trial.

de Seze, J

Effect of glatiramer acetate (Copaxone) given orally in human patients: interleukin-10 production during a phase 1 trial. [electronic resource] - Annals of neurology May 2000 - 686 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase I; Letter; Randomized Controlled Trial

0364-5134


Adjuvants, Immunologic--pharmacology
Administration, Oral
Cytokines--biosynthesis
Double-Blind Method
Glatiramer Acetate
Humans
Interleukin-10--biosynthesis
Multiple Sclerosis--drug therapy
Peptides--pharmacology